Medicago

Contact
medicago.com
+14186589393

Medicago, Inc.

1020, route de l'Église, bureau 600
G1V 3V9 Québec
Canada
+14186589393
medicago.com
Contact
Profile Products News
Contact

About Medicago

Medicago develops vaccines and treatments to help fight emerging global health challenges, today and in the future. Please note that we may come across a situation not outlined above that will require the removal of your comment. Please know that Medicago reserves the right to delete any comment at its sole discretion.

Read more about Medicago
Facts about Medicago
  • Focus : Manufacturer
  • Industry : Pharma

Product portfolio of Medicago

Product portfolio

Show all

News about Medicago

Medicago

21-May-2015 | business & finance

Medicago to build $245M production facility in Quebec City

New complex will make vaccines and therapeutics using innovative plant technology

Read news
Medicago

18-Jan-2012 | business & finance

Medicago and Cellectis Enter into Research Agreement to Improve Therapeutic Proteins Using Nuclease Technology

Medicago Inc.  and Cellectis plant sciences, a subsidiary of Cellectis SA announced the signing of a research agreement under which Medicago and Cellectis ...

Read news
Medicago

12-Apr-2011 | research and development

Medicago announces research collaboration for the development of a non-influenza vaccine candidate

Medicago Inc. announced that it has entered into a research collaboration agreement for the development of a non-influenza vaccine candidate with a top 10 ...

Read news
Medicago

29-Nov-2010 | business & finance

Medicago announces an extension of its agreement with Genopole biopark

Medicago Inc. announced an extension to its partnering agreement of July 2009 with Genopole®. Medicago and Genopole® will also work towards the creation a ...

Read news
Medicago

27-Sep-2010 | research and development

Medicago discovers breakthrough method of preparing plant derived recombinant proteins and VLPs

Medicago Inc. announced it has filed two international patent applications under the Patent Cooperation Treaty (PCT) that broadly cover new methods of ...

Read news
Medicago

12-Aug-2010 | business & finance

Medicago awarded $21 million from the U.S. Department of Defense

Medicago to develop a vaccine facility in Research Triangle Park, North Carolina

Read news
Medicago

19-Mar-2010 | business & finance

Medicago signs MOU with NITT Partners for commercial development of influenza vaccines in Japan

Medicago Inc. announced that it has signed a Memorandum of Understanding with Niigata TLO/NBRP/KUTLO-NITT ("NITT Partners") to discuss and negotiate an ...

Read news
Medicago

13-Oct-2009 | business & finance

Medicago awarded contract by the U.S. Army to explore applications of its plant-based technology in renewable energy

Medicago Inc. announced that it has been awarded a proof of concept contract by the U.S. Army Research, Development and Engineering Command laboratory ...

Read news
Show more news about Medicago

Here you will find Medicago, Inc.